Rhythmic fluctuations of CEA serum levels in breast cancer patients.
Hourly blood sampling for CEA determination was performed in metastatic breast cancer patients before and during medical treatment. Rhythmic fluctuations of marker concentrations could be detected. These oscillations seemed to be independent of the localisation of metastases and the kind of treatment. No relation between cortisol or prolactin and CEA levels became apparent.
Jäger
W
W
Department of Obstetrics and Gynecology, University of Erlangen, F.R.G.
Diedrich
M
M
Sauerbrei
W
W
Wildt
L
L
D000616:Aminoglutethimide / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000556:secondary; D001943:Breast Neoplasms / Q000097:blood* / Q000276:immunology; D002272:Carcinoembryonic Antigen / Q000097:blood*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008113:Liver Neoplasms / Q000556:secondary; D008175:Lung Neoplasms / Q000556:secondary; D009362:Neoplasm Metastasis; D010507:Periodicity; D011388:Prolactin / Q000097:blood; D013629:Tamoxifen / Q000627:therapeutic use
D002272:Carcinoembryonic Antigen; D013629:Tamoxifen; D000616:Aminoglutethimide; D004317:Doxorubicin; D003520:Cyclophosphamide; D011388:Prolactin; D006854:Hydrocortisone